Literature DB >> 19654502

Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls.

Fabio Tavora1, Daniel A Fajardo, Thomas K Lee, Tamara Lotan, Jeremy S Miller, Hiroshi Miyamoto, Jonathan I Epstein.   

Abstract

Technical advances in endoscopic equipment have led to increased ureteroscopic biopsies of the upper urinary tract, resulting in limited biopsy material. We retrospectively reviewed 76 consecutive mid-upper ureter and renal pelvis biopsies submitted for consultation from January 2004 to January 2009, where follow-up was obtainable. There were 49 (64.5%) males and 27 (35.5%) females. Thirty-nine (51.3%) of the biopsies were from the ureter with the remaining 37 (48.7%) from the renal pelvis. The mean age was 70 years for males and 71 for females (range: 24 to 89). At consultation, the most common diagnoses were benign urothelium (n=25, 32.9%); atypical (n=17, 22.4%); low-grade noninvasive papillary urothelial carcinoma (n=10, 13.2%); and high-grade noninvasive papillary urothelial carcinoma (n=8, 10.5%). In cases where a definitive diagnosis could not be reached on expert review, it was mainly because of the limited size of the biopsy, absence of papillary fronds, crush artifact, and distorted architecture. There were 7 major discrepancies between the outside and second opinion diagnosis, where all of the cases were initially diagnosed as an urothelial neoplasm, yet was non-neoplastic upon review. Strips of urothelium without well-developed fibrovascular cores, polypoid ureteritis/pyelitis, and reactive urothelium mimicked urothelial neoplasms. In 5 of these 7 cases, there was no gross lesion suspicious of a tumor present according to the urologist. Overall, 33 of the 44 (75%) cases with a mass noted by the urologist or by radiography was found to have a neoplasm at follow-up. Conversely, 24 of the 32 (75%) cases without a grossly suspected tumor had no neoplasm at follow-up. The association between the histologic presence of a neoplasm at follow-up and the presence of a clinically suspected tumor was highly significant (P<0.0001). Pathologists need to recognize that in almost 1 of the 4 renal pelvic/ureteral biopsies a definitive diagnosis cannot be made because of the inadequate tissue. Caution must be exercised in the evaluation of these limited specimens, especially in the absence of a clinically suspected tumor.

Entities:  

Mesh:

Year:  2009        PMID: 19654502     DOI: 10.1097/PAS.0b013e3181aec42a

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Urothelial carcinoma: Endoscopy to predict outcomes in upper tract urothelial cancer.

Authors:  Ramy F Youssef; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2012-04-03       Impact factor: 14.432

2.  A Novel Technique to Improve the Processing of Minute Ureteroscopic Biopsies.

Authors:  Shay Golan; Glenn Gerber; David Margel; Lea Rath-Wolfson; Yaron Ehrlich; Rumelia Koren; David Lifshitz
Journal:  Pathol Oncol Res       Date:  2017-04-03       Impact factor: 3.201

3.  Diagnostic role of urine cytology and ureteroscopic biopsies in detection of high grade upper tract urothelial carcinoma.

Authors:  Yani Zhao; Fang-Ming Deng; Jonathan Melamed; William C Huang; Hongying Huang; Qinghu Ren
Journal:  Am J Clin Exp Urol       Date:  2021-06-15

4.  Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma.

Authors:  Jay Simhan; Marc C Smaldone; Brian L Egleston; Daniel Canter; Steven N Sterious; Anthony T Corcoran; Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  BJU Int       Date:  2014-04-03       Impact factor: 5.588

Review 5.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Authors:  Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin
Journal:  World J Urol       Date:  2016-05-27       Impact factor: 4.226

Review 6.  Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience.

Authors:  Harun Fajkovic; Tobias Klatte; Udo Nagele; Michael Dunzinger; Richard Zigeuner; Wilhelm Hübner; Mesut Remzi
Journal:  World J Urol       Date:  2012-09-27       Impact factor: 4.226

Review 7.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours.

Authors:  Thomas Seisen; Pierre Colin; Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2015-02-24       Impact factor: 14.432

8.  Urinary cytology with acridine orange fluorescence is highly valuable for predicting high-grade upper urinary tract urothelial carcinoma.

Authors:  Jing Li; Zhihong Zhang; Jin Wang; Changwen Zhang; Haibo Li; Yong Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 9.  Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis?

Authors:  Stephanie P Chen; Joseph C Liao
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

10.  A Pilot Study of In Vivo Confocal Laser Endomicroscopy of Upper Tract Urothelial Carcinoma.

Authors:  Daniel Bui; Kathleen E Mach; Dimitar V Zlatev; Robert V Rouse; John T Leppert; Joseph C Liao
Journal:  J Endourol       Date:  2015-10-06       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.